Clinical Trials · NCT00099086
Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Medical University of South Carolina
- Enrollment
- 20
- Start date
- Jan 2007
- Locations
- See registry
- Primary endpoint
- Maximum tolerated dose (MTD) of Taxotere with radiation therapy and hormonal therapy